Chrome Extension
WeChat Mini Program
Use on ChatGLM

UPDATE ON A PHASE 1 STUDY OF THE SELECTIVE PI3K-DELTA INHIBITOR, IDELALISIB (GS-1101) IN COMBINATION WITH OFATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

HAEMATOLOGICA(2013)

Cited 0|Views21
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined